To investigate whether inhibition of PIKfyve is required for β-catenin nuclear accumulation via the prolonged activation of EGFR in breast cancer cells, we then treated MCF-7 and MDA-MB-231 cells with a PIKfyve specific inhibitor YM201636. This evidence concerns the gene EGFR and breast carcinoma.